| INTRODUCTION
Leishmaniasis is a parasitic infection that is manifested in both animals and humans, and it is caused by several species of protozoa of the genus Leishmania. 1 Twelve million people are affected by the disease worldwide, and approximately 350 million people are currently at risk of infection. 2 Leishmaniasis can be characterized by cutaneous, mucocutaneous, diffuse cutaneous and visceral forms, depending on the species of parasite involved and on the host immune response.
3
Cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis have become a major public health problem in South America, where the infection with Leishmania braziliensis is prevalent. 4 Ulcers with raised hard edges and irregular granulation tissue in the floor are frequent, which represent the classic lesion. 5 Immune response mediated by Th1-like cells, which is mainly represented by production of IFN-γ, appears to be critical to the healing of the injuries caused by Leishmania, whereas Th2 or T regulatory response is associated with infection persistence, in which IL-4, IL-13, IL-10 and TGF-β are highlighted.
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According to some authors, IL-17 and IL-22 may indicate the presence of Th17 profile in the defence against the parasite. 7 IL-22 has been associated with immunity of the skin and mucous membranes against infections, but when produced in high levels or together with other proinflammatory cytokines, it may aggravate the pathology.
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Interleukin 27 has recently been recognized for its antiinflammatory properties in several models of autoimmune and infectious diseases. 9 Some studies have shown IL-27 as a mediator of antiinflammatory activity through its ability to suppress Th17 cells, 10 and together with IL-12 promote the differentiation of naive CD4 T cells towards Th1. ; moreover, it seems to increase at the lesion site in L. donovani infection and display some ability to kill Leishmania in model of resistance and to promote granuloma formation on susceptible strain of mice. 15 However, their participation in the infection with Leishmania spp remains unclear. 16 The potential role of mast cell on the models studied herein is also reinforced by the increase in tissue after PDT.
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Treatment of cutaneous leishmaniasis remains a therapeutic challenge, so more effective therapies are needed. 18 Pentavalent antimonials, such as Glucantime, are the first-line drugs for the treatment of leishmaniasis. They require long treatment with high parenteral dosages that raise the risk of toxicity. 19 The second possibility of treatment, when there is no adequate response to the first line, is the use of pentamidine, paromomycin, miltefosine or amphotericin B.
Nonetheless, some of these drugs are also very toxic or are administered parenterally.
20
Photodynamic therapy (PDT) has been considered, once it may offer an effective alternative to the treatment of CL. This type of therapy was initially used to treat cancer, but it has been studied and used for other purposes, such as the treatment of infectious diseases and dental therapies. 19, 20 PDT mechanism of action is based on a photosensitive substance that is stimulated to energize stage; when back to the ground stage, its energy is transferred to oxygen to produce oxygen free radical or singlet oxygen. 
| METHODS

| Animals
Forty-eight 4-to 6-week-old male BALB/c mice were housed under controlled temperature (22°C) and a 12-hour light-dark cycle, and fed 
| Isolation of amastigote forms of Leishmania
Leishmania braziliensis amastigotes (Lb2904) were maintained in BALB/c mice and used in experimental infection. The footpads of euthanized infected mice were removed, mechanically homogenized and the cell suspension was subjected to centrifugation at 200xg for 10 minutes for sedimentation of debris. The supernatant was collected and centrifuged at 3000×g for 20 minutes. The amastigote pellet was resuspended in PBS and washed three times on the same condition. 24 For the infection, 1 × 10 6 amastigotes in 50 μL of PBS were inoculated intradermally in both hind paw footpads.
| Photodynamic therapy
Four weeks after infection, twelve animals per group were subjected to three PDT treatments with 5-day intervals. Four days after the last session, they were euthanized. Animals of the controls groups were subjected to the different treatments proposed following similar inter- 
| Control groups
To determine the effect of light or ALA alone, twelve infected BALB/c mice were intraperitoneally treated with 150ul of ALA (Sigma) at a dose of 200 mg/kg. The twelve other mice were exposed to light from a hand-held curing light (GNATUS) at a wavelength range of 400-500 nm and an energy density of 50 J/cm². 25 Furthermore, a group of 24 infected animals subjected to no treatment was kept as a control group.
| Smear and microscopic examination
Mice were euthanized 4 days after the last PDT session. The paws were removed and cut in half, and the smear was performed by pressing the paw on the inner side of the slide so as to quantify the number of parasites of the treated animals and the untreated control group.
Smears were air-dried, fixed with cold methanol and stained with Giemsa to determine the number of amastigotes. The results were expressed as the number of amastigotes/100 cells.
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| Mast cell density
The density of mast cells was determined in the histological fragments of the paws stained with Giemsa. Cell density was quantified
| Gene expression
Cytokine expression in each group of animals subjected to different types of treatment was analysed using quantitative reverse transcriptase PCR. Therefore, half of the mice paws were stored in 500 μL 
| Statistical analysis
The variables were analysed using nonparametric tests. Kruskal-Wallis test was applied to compare three or more groups, followed by Dunn's post-test. The difference was considered significant when P<.05. The post hoc Dunn test was used to establish the differences indicated by the Kruskal-Wallis test, with the level of significance set at Q>2.5.
SigmaStat software (Systat, San Jose, CA, USA) was used for statistical analysis.
| RESULTS
| Determination of parasite load
The number of amastigotes per 100 cells was determined by the imprint of paws. Comparison of the parasite load between groups subjected to different types of treatments and the untreated group showed significant differences between the PDT group and the untreated group, and also between the PDT group and the group that received only light, with P<.0001 (Figure 1 ).
| Mast cell density
There was no significant difference (P>.05) in the density of mast cells between the animals without PDT and those that received photodynamic therapy, or only light or 5-ALA (data not shown).
| Expression of cytokines and transcriptions factors
Comparison of the group not receiving photodynamic therapy with the groups treated with ALA, light and PDT clearly evidence an increase in IFN-γ and T-Bet only in animals treated with PDT (Figures 2 and 3 ). Furthermore, a significant decrease in IL-22 and increase in IL-27 expression in the group treated only with light was found ( Figure 2 ). There was no significant difference in mRNA expression for IL-4 or GATA-3 ( Figures 2 and 3) nor IL-17, IL-10 and Foxp3
(data not shown).
| DISCUSSION
Cutaneous leishmaniasis represents an opportunity for the introduction of photodynamic therapy, first due to skin lesions and easily accessible light sources. 5-ALA is a photosensitizer approved for dermatological use in North America and Europe. ALA can be used systemically or locally and is converted into protoporphyrin IX, the photosensitizer molecule, by a large variety of cells.
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Furthermore, the leishmaniasis treatments available today are generally parenteral, long and highly toxic. 25 These factors together cantly reduced lesion, as well as a reduction in the parasite load. 26 In another study with 20 human patients, 5-ALA-mediated PDT was used in 31 lesions of L. major cutaneous leishmaniasis, which resulted in the absence of 100% parasites in the lesions 28 days after therapy; also, the lesions remained free of amastigotes throughout the end of the study. 27 Although some studies have shown favourable results, current treatments for cutaneous leishmaniasis with PDT are able to reduce the parasite load, but they do not completely eradicate the parasites.
28
The results presented herein indicate that PDT combined with 5-ALA was able to reduce parasite load and that this reduction was associated with increased expression of mRNA for IFN-γ and T-Bet.
IFN-γ, a prototype Th1 cytokine, is associated with parasite control, On the other hand, T-Bet represents an IFN-γ transcription factor, corroborating with the idea of a functional Th1 activity. 6, 26 It is well established that the successful control of the infection by Leishmania major requires the development of IFN-γ produced by CD4+ T cells for the induction of microbicidal activity by infected macrophages.
11 IFN-γ and T-Bet were significantly higher in BALB/c mice infected with L. braziliensis after receiving PDT associated with 5-ALA.
Therefore, the reduction of parasites caused by the therapy can be attributed to the direct effect and also to an increase in IFN-γ. Other studies using ELISA reported no significant differences in the levels of IL-12, TNF-α, IFN-γ and IL-10 in mice infected with L.
major and treated with PDT.
In the present study, there was no significant difference in the density of mast cells evaluated in the paws of animals between the group treated with PDT and the untreated group. A description on the participation of mast cells in CL and associations with PDT could not be found in the literature. Studies have shown that mast cells may be involved in tissue repair and in collagen synthesis through the release of mediators. 35 The role of mast cells in leishmaniasis is still not well understood.
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In conclusion, although PDT combined with 5-ALA was effective in reducing the parasite load, it was not able to completely eradicate the parasites. PDT increased mRNA expression of IFN-γ and T-Bet, which, together with the direct effect of PDT, and can contribute to limit tissue parasitism. Therefore, further studies are required to clarify other mechanisms associated with the reduction of the parasite burden in the infection caused by L. braziliensis and the significance of IL-22 and IL-27 modulation induced by treatment with light only observed in infected footpads.
